Biocon Biologics Debuts on the ASIA IP ELITE 2019 List
Biocon has been recognised as the ASIA IP ELITE for the fourth year in a row and its wholly-owned subsidiary Biocon Biologics makes its debut on this prestigious list in 2019 by the IP Business Congress Asia {IPBC Asia) for robust Intellectual Property (IP) management and consistent IP value creation.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
